by EmVenio | May 2, 2024 | Press Release
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 —...
by EmVenio | Apr 16, 2024 | Press Release
Partnership to provide clinical research to patients across the country DURHAM, N.C., April 16, 2024 – Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio...
by EmVenio | Apr 15, 2024 | Blog
The recent World Vaccine Congress proved to be a pivotal moment for the industry, marking achievements, recognition, and inspiring discussions that propel us forward in the realm of clinical trials and vaccine development. As we gather our thoughts and reflections,...
by EmVenio | Mar 26, 2024 | Blog
Over the past few months, EmVenio has led a series of impactful events in Alabama, Illinois, and Florida, to boost community well-being. These local connections raise awareness about the importance of clinical research and offer local residents the opportunity to...
by EmVenio | Feb 23, 2024 | Press Release
EmVenio’s Community Research Site Network helps remove barriers for participation in clinical research for underrepresented communities Denver (February 23, 2024) – Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized...
